Quality of Life and Metabolic Indicators of Patients with Type 2 Diabetes: A Cross-Sectional Study in Iran

Kaveh, Mohammad Hossein; Noori, Keramat; Nazari, Mahin; Khademi, Khadijeh

doi:https://doi.org/10.1155/2022/4046012

International Journal of Endocrinology

On this page

Abstract Introduction Methods Results Discussion Conclusion Data Availability Ethical Approval Consent Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 4046012 | https://doi.org/10.1155/2022/4046012

Quality of Life and Metabolic Indicators of Patients with Type 2 Diabetes: A Cross-Sectional Study in Iran

Mohammad Hossein Kaveh,¹Keramat Noori,²Mahin Nazari,²and Khadijeh Khademi³

Academic Editor: Antonino Catalano

Received18 Aug 2022

Revised17 Nov 2022

Accepted21 Dec 2022

Published28 Dec 2022

Abstract

Background. The World Health Organization (WHO) has considered type 2 diabetes mellitus (T2DM) a major global health challenge because of its high prevalence worldwide. T2DM can affect patients’ personal, social, and economic statuses. On the other hand, due to the increasing prevalence of T2DM, Quality of Life (QOL) has received more attention in recent years. Objective. The present study was conducted to investigate the relationships between QOL and physical activity level, body mass index, fasting blood sugar, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglyceride, total cholesterol, HbA1c, and systolic and diastolic blood pressure among Iranian patients with uncomplicated T2DM. Methods. This cross-sectional study was conducted on 135 participants selected through consecutive sampling. The study data were collected using International Physical Activity Questionnaire and Short-Form Health Survey Questionnaire. Then, the data were entered into the SPSS ver. 28 software, and Pearson’s correlation was used to measure the correlation between the variables. Linear regression was also employed. The significance level was set at 0.05. Results. The significant association was observed between gender (), HDL level (), and gender-adjusted physical activity () with QOL. Conclusions. Due to the association between physical activity and HDL level with QOL in patients with uncomplicated T2DM, they should be given the necessary training to improve their physical activity and regulate HDL level. Also, empowering them in this matter improves their QOL.

1. Introduction

The World Health Organization (WHO) has considered type 2 diabetes mellitus (T2DM) a major global health challenge due to its high prevalence worldwide [1]. There are currently more than 423 million patients [2], the majority of whom live in developing countries [3]. Based on the World Health Report, the prevalence of T2DM in adults has been expected to increase by 64% between 1995 and 2045 (from 135 million to 628 million) [4]. Accordingly, there will be a 42% increase from 51 to 72 million in developed countries and a 170% increase from 84 to 228 million in developing countries. Thus, the proportional increase will be greater in developing countries [2, 5, 6]. In Iran, the prevalence of T2DM is approximately 11.9%. It has also been estimated that 9.2 million patients will suffer from T2DM by 2030 [7].

Studies performed in Iran and some other countries have indicated that T2DM negatively influences the patients’ Quality of Life (QOL) [8–12]. T2DM is, in fact, a costly health problem for patients and the healthcare system that is detected in all age groups and countries [2]. It can affect the personal, social, and economic statuses of patients, increase the prevalence of chronic diseases and dissatisfaction with life, and decrease the QOL. In addition, boring treatments as well as disabling and life-threatening complications of T2DM can affect patients’ physical, psychological, and social health, i.e., QOL [13–16]. Since patients’ QOL may boost their metabolism [17], more attention should be paid to the key determinants of Health-Related QOL (HRQOL) to identify and implement appropriate policies to achieve better T2DM management and improve the patients’ QOL [8]. In this context, it is necessary to determine how T2DM affects patients’ QOL since improving the QOL is among the most important goals of healthcare systems [18].

Studies have indicated that T2DM negatively influences the QOL, but the level of influence has been different across various studies [8–16]. Additionally, contradictory results have been obtained regarding the relationship among QOL, physical activity, and some metabolic indicators, such as body mass index (BMI), triglyceride, hemoglobin A1c (HbA1c), and high-density lipoprotein (HDL) cholesterol that seem to be associated with T2DM [19–22].

Thus, the present study aims to investigate the relationships between QOL and physical activity level, BMI, FBS, HDL, LDL, triglyceride, total cholesterol, HbA1c, and systolic and diastolic blood pressure among Iranian patients with T2DM.

2. Methods

2.1. Study Design, Setting, and Period

This cross-sectional, comparative study was conducted on the participants selected through consecutive sampling of patients with T2DM who had active medical records in Mobarakeh Diabetes Clinic affiliated with the Social Security Organization during January–March 2019.

2.2. Sample Size Determination and Study Participants

The sample size was estimated at a confidence interval of 95% with an acceptable error of 1.85 (3% mean: 61.90) and a standard deviation of 7.50 for the Quality of Life of Iranian patients with T2DM [23, 24]. Then, 135 were included in the study due to the probability of not completing the questionnaires. The inclusion criteria were (1) no mental retardation and (2) writing and reading literacy, and the exclusion criteria included suffering from (1) other diseases or disorders such as cancer, multiple sclerosis, arthritis, dementia, and depression and (2) complications such as diabetes-related neuropathy and nephropathy.

2.3. Data Collection

The data including metabolic indices, FBS, HDL, LDL, triglyceride, total cholesterol, and HbA1c were extracted from the patients’ medical records within 30 days before the survey. Other data including weight and height for estimated BMI and blood pressure were recorded by a specialist on the day the patients attended the clinic for care and treatment. Then, the questionnaires were completed in a separate room within 30 minutes.

2.4. Data Collection Tools

The data were collected using the three self-administered questionnaires: the demographic characteristics questionnaire, the Persian version of the International Physical Activity Questionnaire (IPAQ), and the Persian version of the Short-Form Health Survey Questionnaire (SF-36) [25, 26].

2.4.1. The Demographic Characteristics Questionnaire

It consists of four questions about age, gender, education level, duration of T2DM, and medication treatment of T2DM.

2.4.2. The Persian Version of the International Physical Activity Questionnaire (IPAQ)

This 21-item questionnaire was used to measure the level of physical activity. This instrument classifies the persons in three groups with low(not meeting medium or high criteria), medium (≥ 600 < 3000 MET-minutes per week), and high (≥ 3000 MET-minutes per week) physical activity. The ICC exceeded 0.7. In addition, the Spearman–Brown correlation coefficient was reported to be 0.9.

2.4.3. The Persian Version of the Short-Form Health Survey Questionnaire (SF-36)

This tool was used to evaluate HRQOL. Cronbach’s α coefficients ranged between 0.77 and 0.90 except for the vitality scale (α = 0.65). Convergent validity showed that all correlations above 0.40 ranged between 0.58 and 0.95. Factor analysis identified two principal components that jointly accounted for 65.9% of the variance. The original versions of both questionnaires were used for scoring [27, 28].

2.5. Data Processing and Analysis

After completing the questionnaires, the data were extracted and analyzed using the SPSS ver. 26 software [29]. Descriptive statistics, such as frequency, mean, and standard deviation, were used to describe the variables. In addition, Pearson’s and Spearman’s correlation, independent samples T-test, and one-way ANOVA were used to measure the correlation and relationship between the variables. Linear regression was performed and boxplot was drawn to explore the association between the variables. The significance level was set at 0.05.

3. Results

3.1. The Demographic Characteristics

The mean age of the 135 participants was 58.02 ± 9.4 years, and the mean duration of the disease was 8.81 ± 6.11 years. Furthermore, the majority of them were females and the minority of them had a university education and no medication treatment for diabetes (Table 1).

3.2. The Status of Physical Activity and HRQOL

The mean level of physical activity of participants was 1625.68 ± 1230.30 MET-min/week, and the majority of them were engaged in moderate physical activities (Table 1). Additionally, the mean level of HRQOL was 54 ± 27.63 (Table 2).

3.3. The Level of BMI and Metabolic Indicators

The mean level of BMI, FBS, HDL, LDL, triglyceride, total cholesterol, HbA1c, and systolic and diastolic blood pressure of participants was within the normal range (Table 2).

3.4. The Relationship between Variables

According to Table 3, Pearson’s correlation test showed a significant linear relationship between physical activity (r: 0.20) and HDL level (r: −0.21) with HRQOL (). Moreover, a significant correlation was observed between gender and HRQOL (r: 0.27), education level, and physical activity (r: 0.34) (). In addition, LDL (r: −0.20), HbA1c (r: −0.21) level, and age (r: −0.21) correlated to physical activity (). But with the leveling of physical activity, the relationship between these factors and its levels was not seen. (Table 4).

3.5. The Association between HDL Level, Physical Activity, Gender, and HRQOL

The results of multiple linear regression between gender, physical activity, and HDL level with HRQOL that were significant in Pearson’s analysis are presented in Table 5. Accordingly, gender () and HDL level () were associated with QOL, so that its level was higher in males and lower in the group with HDL level >60 mg/dL () (Figures 1 and 2). After adjusting physical activity for gender (), the association between it and HRQOL was demonstrated (Figure 3). According to Figure 4, men’s physical activity was more intense than women’s physical activity.

4. Discussion

Improving QOL is among the most important goal of the healthcare system; thus, it is important to investigate how diabetes affects patients’ QOL [30, 31]. In the present study, a significant association was observed between HDL level >60 mg/dL and lower HRQOL, which was inconsistent with the results of Xepapadaki et al. [22], while some studies have shown that higher consumption of HDL is related to improved cardiovascular function, and lower consumption is associated with mental and cognitive disorders and subsequently better QOL. [32–34b32 b33 b34. In other studies, the high level of HDL was not confirmed as a protective factor for cardiovascular diseases, and the quality of HDL’s function may be more important than its quantity for this matter [35, 36]. Hence, future research studies are needed to explore these relationships.

The present study showed no significant correlation between FBS, HbA1c, blood pressure, cholesterol level, and HRQOL, while other studies showed significant correlations using the 5-levelEuroQoL-5 dimensions (EQ-5D-5L) questionnaire or World Health Organization Quality of Life (WHOQOL-BREF) short-form questionnaire [21, 37, 38]. The difference in this correlation between the studies could be attributed to utilizing different questionnaires with different number of questions in the extent of dimensions on the relevant topic.

Another finding of our study was the association between male gender and higher HRQOL. Similarly, Castellano-Guerrero et al. and Huebschmann et al. had shown this relationship [39, 40]. It seems that the sociocultural and health behavior differences between men and women could be a reason for it.

In addition, the findings of the present study showed a significant association between the total score of HRQOL and the gender-adjusted physical activity, which was supported by Thiel et al.’s study [41]. Similarly, Xu et al. revealed a significant positive correlation between physical activity and QOL in patients with T2DM [42]. It should be noted that the best type of physical activity for people with T2DM is aerobic exercise, especially if it is done daily [43, 44]. This finding warns us to adopt appropriate supportive policies to improve education and provide environmental support for promoting physical activity in society, especially among women.

According to the findings of the present study, similar studies are recommended to be conducted on patients with chronic diseases in different age groups and population-based sampling methods. The results of this study can be effective in improving educational methods, as an effective factor in patients’ self-management of chronic diseases.

The present study had some limitations including incomplete questionnaires, difficulties in having access to patients, and patients’ low literacy levels that caused difficulties in completing the questionnaires. Other limitations were conducting the study in only one center, volunteer sampling, and data collection through self-report that could affect the generalizability of the results. In addition, the results might have been affected by personality differences and the lack of a healthy control group.

5. Conclusion

The results of the present study show that performing physical activity and regulating HDL levels could improve HRQOL in patients with T2DM. Therefore, according to the status of these factors in them, appropriate health programs such as self-directed group physical activity, team sports, and recreational sports, such as mountain climbing should be implemented to improve their QOL.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Ethical Approval

Ethical approval was acquired from the Research Ethics Committee (REC) of Shiraz University of Medical Sciences (SUMS) under approval ID: IR.SUMS.REC.1397.621, in 2018. All of the methods were performed in accordance with the relevant guidelines and regulations.

Written informed consent was obtained from participants.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

MHK supervised all of the processes from registering the project proposal until final editing of the manuscript as a supervisor. KN collected the data. KH analyzed the data and wrote the manuscript. MN participated in correcting the title of the project, choosing the instrument, and conducting the study as an advisor. All authors read and approved the final version of the manuscript.

Acknowledgments

The authors would like to thank their colleagues for their valuable comments.

References

World Health Organization, “Global Report on Diabetes. 21 April 2016,” pp. 1–86, 2020, https://www.who.int/publications/i/item/9789241565257.
View at: Google Scholar
E. Standl, K. Khunti, T. B. Hansen, and O. Schnell, “The global epidemics of diabetes in the 21st century: current situation and perspectives,” European Journal of Preventive Cardiology, vol. 26, no. 2, pp. 7–14, 2019.
View at: Publisher Site | Google Scholar
A. Misra, H. Gopalan, R. Jayawardena et al., “Diabetes in developing countries,” Journal of Diabetes, vol. 11, no. 7, pp. 522–539, 2019.
View at: Publisher Site | Google Scholar
B. Zhou, Y. Lu, K. Hajifathalian et al., “Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants,” The Lancet, vol. 387, no. 10027, pp. 1513–1530, 2016.
View at: Publisher Site | Google Scholar
International Diabetes Federation (IDF), “IDF Diabetes Atlas,” 2017, http://diabetesatlas.org/resources/2017-atlas.html.
View at: Google Scholar
International Diabetes Federation (IDF), “Webinars on circulatory health and COVID-19,” 2019, https://idf.org/52-about-diabetes.html.
View at: Google Scholar
A. Esteghamati, B. Larijani, M. H. Aghajani et al., “Diabetes in Iran: prospective analysis from first nationwide diabetes report of national program for prevention and control of diabetes (NPPCD-2016),” Scientific Reports, vol. 7, no. 1, Article ID 13461, 2017.
View at: Publisher Site | Google Scholar
L. Palamenghi, M. M. Carlucci, and G. Graffigna, “Measuring the quality of life in diabetic patients: a scoping review,” Journal of Diabetes Research, vol. 2020, Article ID 5419298, 19 pages, 2020.
View at: Publisher Site | Google Scholar
I. F. A. Tonetto, M. H. B. Baptista, D. D. S. Gomides, and A. E. Pace, “Quality of life of people with diabetes mellitus,” Revista da Escola de Enfermagem da USP, vol. 53, Article ID e03424, 2019.
View at: Publisher Site | Google Scholar
M. R. Abedini, B. Bijari, Z. Miri, F. Shakhs Emampour, and A. Abbasi, “The quality of life of the patients with diabetes type 2 using EQ-5D-5 L in Birjand,” Health and Quality of Life Outcomes, vol. 18, no. 1, p. 18, 2020.
View at: Publisher Site | Google Scholar
A. Y. Aschalew, M. Yitayal, and A. Minyihun, “Health-related quality of life and associated factors among patients with diabetes mellitus at the University of Gondar referral hospital,” Health and Quality of Life Outcomes, vol. 18, no. 1, p. 62, 2020.
View at: Publisher Site | Google Scholar
A. Darvishpoor Kakhki and Z. Abed Saeedi, “Health-related quality of life of diabetic patients in tehran,” International Journal of Endocrinology and Metabolism, vol. 11, no. 4, Article ID e7945, 2013.
View at: Publisher Site | Google Scholar
S. Assari, M. Moghani Lankarani, J. D. Piette, and J. E. Aikens, “Socioeconomic status and glycemic control in type 2 diabetes; race by gender differences,” Health Care, vol. 5, no. 4, p. 83, 2017.
View at: Publisher Site | Google Scholar
J. Walker, H. Colhoun, S. Livingstone et al., “Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012-2014): a population-based observational study,” Diabetologia, vol. 61, no. 1, pp. 108–116, 2018.
View at: Publisher Site | Google Scholar
A. K. AbuAlhommos, A. H. Alturaifi, A. M. Al-Bin Hamdhah, H. H. Al-Ramadhan, Z. A. Al Ali, and H. J. Al Nasser, “The health-related quality of life of patients with type 2 diabetes in Saudi arabia,” Patient Preference and Adherence, vol. 16, pp. 1233–1245, 2022.
View at: Publisher Site | Google Scholar
D. Alshayban and R. Joseph, “Health-related quality of life among patients with type 2 diabetes mellitus in Eastern Province, Saudi Arabia: a cross-sectional study,” PLoS One, vol. 15, no. 1, Article ID e0227573, 2020.
View at: Publisher Site | Google Scholar
R. B. da Rocha, C. S. Silva, and V. S. Cardoso, “Self-care in adults with type 2 diabetes mellitus: a systematic review,” Current Diabetes Reviews, vol. 16, no. 6, pp. 598–607, 2020.
View at: Publisher Site | Google Scholar
Center for Disease Control and Prevention (Cdc), “Diabetes,” 2020, https://www.cdc.gov/globalhealth/healthprotection/ncd/diabetes.html.
View at: Google Scholar
Y. C. Lai, Y. M. Liao, and P. C. Lin, “Physical activity and quality of life in patients with type II diabetes mellitus,” Hu Li Za Zhi, vol. 66, no. 2, pp. 57–66, 2019.
View at: Publisher Site | Google Scholar
I. K. Thorsen, Y. Yang, L. S. Valentiner et al., “The effects of a lifestyle intervention supported by the InterWalk smartphone app on increasing physical activity among persons with type 2 diabetes: parallel-group, randomized trial,” JMIR Mhealth Uhealth, vol. 10, no. 9, Article ID e30602, 2022.
View at: Publisher Site | Google Scholar
J. L. Cepeda Marte, C. Ruiz-Matuk, M. Mota et al., “Quality of life and metabolic control in type 2 diabetes mellitus diagnosed individuals,” Diabetes & Metabolic Syndrome: Clinical Research Reviews, vol. 13, no. 5, pp. 2827–2832, 2019.
View at: Publisher Site | Google Scholar
E. Xepapadaki, I. Nikdima, E. C. Sagiadinou, E. Zvintzou, and K. E. Kypreos, “HDL and type 2 diabetes: the chicken or the egg?” Diabetologia, vol. 64, no. 9, pp. 1917–1926, 2021.
View at: Publisher Site | Google Scholar
A. Dehkordi, M. Ramezanpour, M. Fakhri, M. Abdan, and D. Sarikhani, “Systematic review and meta-analysis on quality of life in diabetic patients in Iran,” International Journal of Preventive Medicine, vol. 12, no. 1, p. 41, 2021.
View at: Publisher Site | Google Scholar
O. A. Bolarinwa, “Sample size estimation for health and social science researchers: the principles and considerations for different study designs,” The Nigerian Postgraduate Medical Journal, vol. 27, no. 2, pp. 67–75, 2020.
View at: Publisher Site | Google Scholar
C. L. Craig, A. L. Marshall, M. Sjöström et al., “International physical activity questionnaire: 12-country reliability and validity,” Medicine & Science in Sports & Exercise, vol. 35, no. 8, pp. 1381–1395, 2003.
View at: Publisher Site | Google Scholar
A. Vasheghani-Farahani, M. Tahmasbi, H. Asheri, H. Ashraf, S. Nedjat, and R. Kordi, “The Persian, last 7-day, long form of the International Physical Activity Questionnaire: translation and validation study,” Asian Journal of Sports Medicine, vol. 2, no. 2, pp. 106–116, 2011.
View at: Publisher Site | Google Scholar
J. E. Brazier, R. Harper, N. M. Jones et al., “Validating the SF-36 health survey questionnaire: new outcome measure for primary care,” BMJ, vol. 305, no. 6846, pp. 160–164, 1992.
View at: Publisher Site | Google Scholar
A. Montazeri, A. Goshtasebi, M. Vahdaninia, and B. Gandek, “The Short Form Health Survey (SF-36): translation and validation study of the Iranian version,” Quality of Life Research, vol. 14, no. 3, pp. 875–882, 2005.
View at: Publisher Site | Google Scholar
IBM Corp, “IBM SPSS Statistics for Windows,” 2019, https://www.ibm.com/support/pages/downloading-ibm-spss-statistics-260.
View at: Google Scholar
J. Speight, E. Holmes-Truscott, C. Hendrieckx, S. Skovlund, and D. Cooke, “Assessing the impact of diabetes on quality of life: what have the past 25 years taught us?” Diabetic Medicine, vol. 37, no. 3, pp. 483–492, 2020.
View at: Publisher Site | Google Scholar
K. Winkley, R. Upsher, D. Stahl et al., “Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review,” Health Technology Assessment, vol. 24, no. 28, pp. 1–232, 2020.
View at: Publisher Site | Google Scholar
X. L. Huang, J. H. Pan, D. Chen, J. Chen, F. Chen, and T. T. Hu, “Efficacy of lifestyle interventions in patients with type 2 diabetes: a systematic review and meta-analysis,” European Journal of Internal Medicine, vol. 27, pp. 37–47, 2016.
View at: Publisher Site | Google Scholar
L. Hui, X. L. Yin, J. Chen et al., “Association between decreased HDL levels and cognitive deficits in patients with bipolar disorder: a pilot study,” Int J Bipolar Disord, vol. 7, no. 1, p. 25, 2019.
View at: Publisher Site | Google Scholar
Q. F. Jia, H. X. Yang, N. N. Zhuang et al., “The role of lipoprotein profile in depression and cognitive performance: a network analysis,” Scientific Reports, vol. 10, no. 1, Article ID 20704, 2020.
View at: Publisher Site | Google Scholar
N. A. Zakai, J. Minnier, M. M. Safford et al., “Race-dependent association of high-density lipoprotein cholesterol levels with incident coronary artery disease,” Journal of the American College of Cardiology, vol. 80, no. 22, pp. 2104–2115, 2022.
View at: Publisher Site | Google Scholar
National Institutes of Health (NIH), “Study challenges “good” cholesterol’s role in universally predicting heart disease risk,” 2022, https://www.nih.gov/news-events/news-releases/study-challenges-good-cholesterol-s-role-universally-predicting-heart-disease-risk.
View at: Google Scholar
G. T. Gebremariam, S. Biratu, M. Alemayehu et al., “Health-related quality of life of patients with type 2 diabetes mellitus at a tertiary care hospital in Ethiopia,” PLoS One, vol. 17, no. 2, Article ID e0264199, 2022.
View at: Publisher Site | Google Scholar
X. Jing, J. Chen, Y. Dong et al., “Related factors of quality of life of type 2 diabetes patients: a systematic review and meta-analysis,” Health and Quality of Life Outcomes, vol. 16, no. 1, p. 189, 2018.
View at: Publisher Site | Google Scholar
A. M. Castellano-Guerrero, R. Guerrero, D. Ruiz-Aranda et al., “Gender differences in quality of life in adults with long-standing type 1 diabetes mellitus,” Diabetology & Metabolic Syndrome, vol. 12, p. 64, 2020.
View at: Publisher Site | Google Scholar
A. G. Huebschmann, R. R. Huxley, W. M. Kohrt, P. Zeitler, J. G. Regensteiner, and J. E. B. Reusch, “Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course,” Diabetologia, vol. 62, no. 10, pp. 1761–1772, 2019.
View at: Publisher Site | Google Scholar
D. M. Thiel, F. Al Sayah, J. K. Vallance, S. T. Johnson, and J. A. Johnson, “Association between physical activity and health-related quality of life in adults with type 2 diabetes,” Canadian Journal of Diabetes, vol. 41, no. 1, pp. 58–63, 2017.
View at: Publisher Site | Google Scholar
H. Xu, L. Tang, Z. Hu et al., “Association between physical activity and health-related quality of life in elderly individuals with pre-diabetes in rural Hunan Province, China: a cross-sectional study,” BMJ Open, vol. 8, no. 4, Article ID e019836, 2018.
View at: Publisher Site | Google Scholar
H. Cai, G. Li, P. Zhang, D. Xu, and L. Chen, “Effect of exercise on the quality of life in type 2 diabetes mellitus: a systematic review,” Quality of Life Research, vol. 26, no. 3, pp. 515–530, 2017.
View at: Publisher Site | Google Scholar
F. Zhang, L. Huang, and L. Peng, “The degree of influence of daily physical activity on quality of life in type 2 diabetics,” Frontiers in Psychology, vol. 11, p. 1292, 2020.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Mohammad Hossein Kaveh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

374

Downloads

360

Citations